Skip to main content
Clinical Trials/NCT06459245
NCT06459245
Enrolling By Invitation
Not Applicable

Resistance Training to Prevent Lymphedema After Breast Cancer Surgery Randomized Controlled Study

Yue WANG1 site in 1 country30 target enrollmentJune 18, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer Female
Sponsor
Yue WANG
Enrollment
30
Locations
1
Primary Endpoint
Lymphedema occurrence
Status
Enrolling By Invitation
Last Updated
11 months ago

Overview

Brief Summary

Breast cancer-related lymphedema is one of the most common chronic complications of breast cancer survivors. In existing studies, the reported incidence of lymphedema ranges from 2.5% to 42.9% . At present, there is no cure for lymphedema. Resistance training has been proved by many studies to alleviate the symptoms of lymphedema, improve the muscle strength of the upper limbs of patients, and improve the quality of life of patients, while not worsening lymphedema. Based on the best evidence, this study intends to construct resistance appropriate for this clinical scenario Training program: Conduct 3-month intervention for patients after breast cancer surgery to explore the effect of resistance training on the grip strength of the affected limb, the range of motion of the shoulder joint of the affected limb, the occurrence of lymphedema of the affected limb, quality of life, etc.

Registry
clinicaltrials.gov
Start Date
June 18, 2024
End Date
June 24, 2025
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Yue WANG
Responsible Party
Sponsor Investigator
Principal Investigator

Yue WANG

Yue WANG Deputy director

Peking University First Hospital

Eligibility Criteria

Inclusion Criteria

  • It was first diagnosed as grade I to III unilateral breast cancer by pathological examination; Breast cancer surgery was completed and axillary lymph node dissection was performed; To receive postoperative adjuvant treatment and follow-up in the outer fourth ward; Be able to communicate and exchange normally; Volunteer to participate in this research

Exclusion Criteria

  • Extreme fatigue, severe anemia, ataxia, etc.; The presence of upper limb or shoulder problems from breast cancer treatment; Edema is in a non-stable stage (stable stage of edema means no treatment for edema in the past 3 months; No inflammation of the upper extremities requiring anti-infective treatment; No change in daily activities; Limb circumference change \< 10%) ; Limited limb movement due to trauma, shoulder periarthritis, etc.; Limb braking is required for health reasons. Patients are lost to follow-up

Outcomes

Primary Outcomes

Lymphedema occurrence

Time Frame: 3 months after intervention

Tissue and local edema due to obstruction of lymphatic drainage

Study Sites (1)

Loading locations...

Similar Trials